GemVax & KAEL Co Ltd
KOSDAQ:082270
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
GemVax & KAEL Co Ltd
Additional Paid In Capital
GemVax & KAEL Co Ltd
Additional Paid In Capital Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
G
|
GemVax & KAEL Co Ltd
KOSDAQ:082270
|
Additional Paid In Capital
₩109.4B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-2%
|
|
|
Hanmi Semiconductor Co Ltd
KRX:042700
|
Additional Paid In Capital
₩65.4m
|
CAGR 3-Years
-84%
|
CAGR 5-Years
-66%
|
CAGR 10-Years
-42%
|
|
|
E
|
EO Technics Co Ltd
KOSDAQ:039030
|
Additional Paid In Capital
₩66.9B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
|
W
|
Wonik IPS Co Ltd
KOSDAQ:240810
|
Additional Paid In Capital
₩357.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
I
|
ISC Co Ltd
KOSDAQ:095340
|
Additional Paid In Capital
₩287.6B
|
CAGR 3-Years
35%
|
CAGR 5-Years
32%
|
CAGR 10-Years
15%
|
|
|
J
|
Jusung Engineering Co Ltd
KOSDAQ:036930
|
Additional Paid In Capital
₩109B
|
CAGR 3-Years
0%
|
CAGR 5-Years
0%
|
CAGR 10-Years
-3%
|
|
GemVax & KAEL Co Ltd
Glance View
GemVax & KAEL Co., Ltd. engages in the production of chemical filters and gas scrubbers for semiconductors. The company is headquartered in Daejeon, Daejeon. The company went IPO on 2005-06-24. The firm and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The firm distributes its products within domestic market and to overseas markets.
See Also
What is GemVax & KAEL Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
109.4B
KRW
Based on the financial report for Dec 31, 2025, GemVax & KAEL Co Ltd's Additional Paid In Capital amounts to 109.4B KRW.
What is GemVax & KAEL Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
-2%
Over the last year, the Additional Paid In Capital growth was -43%. The average annual Additional Paid In Capital growth rates for GemVax & KAEL Co Ltd have been -16% over the past three years , -9% over the past five years , and -2% over the past ten years .
